Compugen Still Confident Of Its TIGIT Strategy Despite Roche’s Setbacks

Highlights Triple Blockade Strategy And Differentiated TIGIT Molecule

Tel Aviv
Compugen is headquartered near Israel's life sciences hub, Tel Aviv. • Source: Shutterstock

More from Business

More from Scrip